Absci News Today : Breaking News, Live Updates & Top Stories | Vimarsana

launched by summit president sultan al—jaber, saying they "clearly fall short of what is required." countries and oil companies at the un climate talks have promised to make major progress in tackling global warming in a large new energy pledge. around 100 countries promised to treble world renewable energy use by 2030. but guterres points out the agreement "says nothing about eliminating emissions "from fossil fuel consumption. " let's fill you in more detail in the comments by the chair of cop28, the sultan al—jaber, as my colleague explains. he is the cop28 president, sultan a...

Absci Co. (NASDAQ:ABSI – Free Report) – HC Wainwright increased their FY2025 earnings estimates for shares of Absci in a report released on Monday, January 8th. HC Wainwright analyst S. Ramakanth now expects that the company will post earnings of ($0.23) per share for the year, up from their previous estimate of ($0.30). HC Wainwright […]

Sir Pangalos is a distinguished biopharmaceutical executive who led BioPharmaceuticals R&D at AstraZeneca. In addition to joining Absci’s Board, Sir Pangalos will co-chair Absci’s Scientific Advisory Board. VANCOUVER, Wash., Jan. 10, 2024 (GLOBE NEWSWIRE) -- Absci (Nasdaq: ABSI), a generative AI drug creation company, today announced the appointment of seasoned R&D executive Professor Sir Menelas “Mene” Pangalos to its Board of Directors and as co-chair of Absci’s Scientific Advisory Board. Sir

The Healthtech Times is a weekly newsletter covering healthtech news from Canada and around the globe.

KeyCorp initiated coverage on shares of Absci (NASDAQ:ABSI – Free Report) in a research note published on Tuesday morning, Marketbeat reports. The firm issued an overweight rating and a $3.00 price target on the stock. KeyCorp also issued estimates for Absci’s Q4 2023 earnings at ($0.22) EPS, FY2023 earnings at ($1.17) EPS and FY2024 earnings […]